News Announcement

Parabolic Drugs: Board Meeting Intimation for Revised Intimation Under Regulation 29 Of SEB (LODR) Regulations 2015 Regarding Unaudited Quarterly Financial Results For The Quarter And Half Year Ended On 30Th September 2020.

Parabolic Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2020 inter alia to consider and approve

Quarter and half year ended on 30th September 2020
Pursuant to letter dated 06th November 2020 where the Company had intimated to the Stock Exchange that Un-audited Financial Results for the Quarter and half year ended on 30th September 2020 be considered and disseminated on Thursday 12th November 2020 but now it hereby decided that due to non-availability Resolution Professional (RP) we are unable to disseminate the same on 12th November 2020 and rather than the Un-audited Financial Results for the Quarter and half year ended on 30th September 2020 will consider and disseminate on Friday the 13th November 2020.

You are requested to display the same on the Notice Board of your Exchange for the information of members and general public.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan